MS BioNTech WKN: A2PSR2 ISIN: US09075V1026 Forum: Aktien User: Thekla

🇺🇦 "So, there is -- that's the main reason why we have been cautious in terms of looking at our guidance of 18 to 17. I think overall, if you look at the 9.6 billion euros that we have reported for the first six months, I mean we feel very, very good about it. And just to maybe allude also to what we said in the Q1 call on the basis of 2.4 billion euros doses we said, we will end up somewhere in the middle of that range. So, of course, there are some fluctuations that we have seen already last year, you know, when that delivery moved from one month into the next month that can happen over the end of the quarter, over the end of the year as well, of course. So -- and all this, you know, just keeps us with the guidance that we have given to you on 13 to 17. But we are, overall, very optimistic, you know, that we will see a good year 2022."

danke, aber das waren "Market-Orders", also ohne Angabe eines Preises oder Limits, das ist doch Betrug, oder nicht? Trade Republic... Habe die Verkaufsabrechnung ja vorliegen, und dann die Stornierung... echt blöd.